170 related articles for article (PubMed ID: 24390211)
1. Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers.
Yoon HI; Koom WS; Kim YB; Min BS; Lee KY; Kim NK; Shin SJ; Ahn JB; Keum KC
J Cancer Res Clin Oncol; 2014 Mar; 140(3):399-409. PubMed ID: 24390211
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.
Yeo SG; Kim DY; Chang HJ; Park JW; Oh JH; Kim BC; Baek JY; Kim SY; Kim TH
Tumori; 2013; 99(1):93-9. PubMed ID: 23549007
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
Wang P; Wang Z; Liu Y; Xie J; Ren Y
Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
[TBL] [Abstract][Full Text] [Related]
4. Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?
Menon A; Abraham AG; Mahfouz M; Thachuthara JJ; Usmani N; Warkentin H; Ghosh S; Nijjar T; Severin D; Tankel K; Paulson K; Mulder K; Roa W; Joseph K
Am J Clin Oncol; 2021 Sep; 44(9):487-494. PubMed ID: 34269694
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M
World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
[TBL] [Abstract][Full Text] [Related]
7. Predictors of sensitivity to preoperative chemoradiotherapy of rectal adenocarcinoma.
Yan H; Wang R; Zhu K; Zhao W; Jiang S; Feng R; Xu X; Meng X; Sun H; Zhang H; Mu D; Xu Z
Tumori; 2011; 97(6):717-23. PubMed ID: 22322837
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY
Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
[TBL] [Abstract][Full Text] [Related]
10. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
Yang KL; Yang SH; Liang WY; Kuo YJ; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Chu LS; Wang LW
Radiat Oncol; 2013 Mar; 8():43. PubMed ID: 23452434
[TBL] [Abstract][Full Text] [Related]
12. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
[TBL] [Abstract][Full Text] [Related]
13. Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study.
Knight KA; Drami I; McMillan DC; Horgan PG; Park JH; Jenkins JT; Roxburgh CSD
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3409-3420. PubMed ID: 33710416
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
15. Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer.
Buijsen J; van Stiphout RG; Menheere PP; Lammering G; Lambin P
Radiother Oncol; 2014 May; 111(2):237-42. PubMed ID: 24746569
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant conformal chemoradiation with induction chemotherapy for rectal adenocarcinoma. A prospective observational study.
Fekete Z; Muntean AS; Hica Ş; Rancea A; Resiga L; Csutak C; Todor N; Nagy VM
J Gastrointestin Liver Dis; 2014 Jun; 23(2):171-8. PubMed ID: 24949609
[TBL] [Abstract][Full Text] [Related]
18. Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.
Garcia-Aguilar J; Chen Z; Smith DD; Li W; Madoff RD; Cataldo P; Marcet J; Pastor C
Ann Surg; 2011 Sep; 254(3):486-92; discussion 492-3. PubMed ID: 21865946
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.
Tokuhara K; Ueyama Y; Nakatani K; Yoshioka K; Kon M
World J Surg Oncol; 2016 Apr; 14():136. PubMed ID: 27129578
[TBL] [Abstract][Full Text] [Related]
20. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]